The market size of the Surgical Drapes Market was around US$ 1.4 Billion in 2023, and now it is expected to grow with a compound annual growth rate (CAGR) of 4.2% for the period of 2023 to 2033.
The surgical drapes market has been driven in recent years by an increase in the number of surgical procedures and increased awareness of the spread of various illnesses. The market is expected to account for an absolute dollar opportunity of nearly US$ 728.3 Million from 2023 to 2033.
Attribute | Details |
---|---|
Global Surgical Drapes Market (2023) | US$ 1.4 Billion |
Surgical Drapes Market (2033) | US$ 2.1 Billion |
Market CAGR (2023 to 2033) | 4.2% |
USA Surgical Drapes Market CAGR (2023 to 2033) | 4% |
Key Companies Profiled |
|
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
As per the Surgical Drapes Market industry research by Future Market Insights - a market research and competitive intelligence provider, historically, from 2018 to 2022, the market increased at a CAGR of 3.6%. The market is projected to grow at a CAGR of 4.2% over the coming ten years.
Increasing demand for patient and healthcare worker protection, as well as an increase in the occurrence of the surgical site and hospital-acquired infections, are fueling market expansion. Operating drapes act as a physical barrier, preventing contamination of the surgical field. Surgical drapes will be in high demand as the number of procedures increases.
In 2018, 17.7 million cosmetic operations and minimally invasive treatments were conducted in the United States, according to the American Society of Plastic Surgeons (ASPS). Around 70 million surgical procedures are performed in Europe each year, according to Molnlycke Health Care AB, with an annual growth rate of 3% to 4%.
In 2018, at least 1.16 million caesarean sections were performed in the EU-27, according to Eurostat data. As a result, market growth is likely to be aided by an increase in surgical procedures performed throughout the forecast period.
HAIs are a leading cause for concern for both patients and doctors around the world. The demand for surgical drapes will be increased further by an increase in hospitalizations and HAIs globally. CDC estimates that roughly one out of 31 hospitalized patients will contract a healthcare-associated infection annually.
According to NHSN Surgical Site Infection (SSI) Surveillance statistics, 157,500 SSI infections are expected to occur annually in the United States. With an estimated annual cost of US$ 3.3 billion and 1 million additional hospital days, SSI is the costliest HAI type. They are also a leading cause of morbidity, prolonged hospitalization, unplanned readmissions following surgery, and mortality. As a result, the market expansion is likely to be fueled by the rising prevalence of HAIs and SSIs worldwide.
An increase in the occurrence of chronic diseases around the world is another key factor driving the market forward. According to the American Heart Association, by 2035, more than 130 million people, or 45.1% of the adult population in the United States, could be suffering from some type of CVD. According to the Centers for Disease Control and Prevention, around 655,000 Americans die each year from heart disease, accounting for one out of every four deaths.
According to the CDC, 6 out of 10 persons in the United States suffer from a chronic disease, with 4 out of 10 having two or more chronic conditions. As a result of the rising patient pool, more surgeries and hospitalizations are performed, resulting in a higher demand for surgical drapes.
During the predicted period, the surgical drapes market in North America is expected to increase significantly. The well-developed infrastructure, rising surgical procedures, and an increase in surgical site infections are all contributing to market expansion.
According to CMS.gov, healthcare spending in the United States climbed by 4.6% in 2019, reaching US$ 3.8 trillion per person, accounting for 17.7% of the country's GDP.
According to the Journal of Infectious Disease Advisor, around 27 million surgical operations are conducted in the USA each year, with up to 5% of these procedures resulting in surgical site infections. In addition, rising healthcare costs are a driving force for market expansion.
The China surgical drapes market grew at a CAGR of 3.8% from 2018 to 2022 and is expected to grow with a CAGR of 5.8% during the forecast period. The market continues to grow since the number of medical procedures keeps rising and the population keeps on growing. Expanded technological advances in the healthcare sector and increased research and development activities are forecast to provide newly promising opportunities in the future for healthcare services.
Medical tourism's booming growth in China has resulted in increasing demand for surgical drapes. The market in China is anticipated to have an absolute dollar growth of US$ 106.9 Million from 2023 to 2033.
The United States surgical drapes market is expected to grow to be worth US$ 758.4 Million by 2033, with an absolute dollar growth of US$ 245.2 Million from 2033 to 2033. The market in the United States has grown at a CAGR of 4.3% from 2018 to 2022 and is expected to grow at a CAGR of 4% from 2023 to 2033.
The market in the United Kingdom is expected to grow to be worth US$ 95.9 Million by 2033, with an absolute dollar growth of US$ 30.2 Million from 2023 to 2033. The market in the United Kingdom grew at a CAGR of 2.4% from 2018 to 2022 and is expected to grow at a CAGR of 3.8% from 2023 to 2033.
Japan's surgical drapes market is expected to grow to be worth US$ 93.3 Million by 2033, with an absolute dollar growth of US$ 39.3 Million. The market in the country grew at a CAGR of 3.5% from 2018 to 2022 and is expected to grow at a CAGR of 5.7% from 2023 to 2033.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Over the projected period, the market for disposable surgical drapes is expected to grow at a CAGR of 4.8%. Disposable drapes are usually constructed of materials that are non-woven and thrown away after each surgery.
It has several advantages, including low cost, decreased manufacturing expenses, low weight, and easy recycling. Disposable surgical drapes are also more resistant to liquids, abrasion, and tearing than reusable surgical drapes. As a result of the aforementioned benefits of non-woven cloth, disposable surgical drapes are in high demand.
In 2020, the hospital segment accounted for more than 40% of the total revenue. Hospitals are the primary consumers of surgical drapes since they perform the bulk of surgeries globally. Furthermore, as the occurrence of SSI rises, surgical drapes grew significantly in demand in hospitals.
The prevalence of SSI is around 24.6%, according to a report published in Bio Med Central (BMC), with 10% developing deep site SSI, 9.2% developing organ spacing SSI, and 5.2% developing surface space SSI. Furthermore, individuals who had undergone orthopaedic and abdominal procedures exhibited a significant frequency of the condition.
The key players in the global Surgical Drapes market are 3M, Steris, Cardinal Health, Paul Hartmann AG, and Mölnlycke Health Care.
The market boosted at a CAGR of 3.6% from 2018 to 2022.
Through 2033, the market is to develop at a CAGR of 4.2%.
By 2033, the market is to have expanded to US$ 2.1 Billion.
In 2023, the market is anticipated to reach a worth of US$ 1.4 Billion.
The market in China is expected to thrive at a CAGR of 5.8%.
From 2023 to 2033, the market in the United Kingdom is poised to develop at a CAGR of 3.8%.
1. Executive Summary | Surgical Drapes Market
1.1. Global Market Outlook
1.2. Summary of Statistics
1.3. Key Market Characteristics & Attributes
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Risks and Trends Assessment
3.1. Risk Assessment
3.1.1. COVID-19 Crisis and Impact on
3.1.2. COVID-19 Impact Benchmark with Previous Crisis
3.1.3. Impact on Market Value (US$ Million)
3.1.4. Assessment by Key Countries
3.1.5. Assessment by Key Market Segments
3.1.6. Action Points and Recommendation for Suppliers
3.2. Key Trends Impacting the Market
3.3. Formulation and Product Development Trends
4. Market Background
4.1. Market, by Key Countries
4.2. Market Opportunity Assessment (US$ Million)
4.2.1. Total Available Market
4.2.2. Serviceable Addressable Market
4.2.3. Serviceable Obtainable Market
4.3. Market Scenario Forecast
4.3.1. Demand in optimistic Scenario
4.3.2. Demand in Likely Scenario
4.3.3. Demand in Conservative Scenario
4.4. Investment Feasibility Analysis
4.4.1. Investment in Established Markets
4.4.1.1. In Short Term
4.4.1.2. In Long Term
4.4.2. Investment in Emerging Markets
4.4.2.1. In Short Term
4.4.2.2. In Long Term
4.5. Forecast Factors - Relevance & Impact
4.5.1. Top Companies Historical Growth
4.5.2. Growth in Automation, By Country
4.5.3. Patch Management Adoption Rate, By Country
4.6. Market Dynamics
4.6.1. Market Driving Factors and Impact Assessment
4.6.2. Prominent Market Challenges and Impact Assessment
4.6.3. Patch Management Market Opportunities
4.6.4. Prominent Trends in the Global Market & Their Impact Assessment
5. Key Success Factors
5.1. Manufacturers’ Focus on Low Penetration High Growth Markets
5.2. Banking on with Segments High Incremental Opportunity
5.3. Peer Benchmarking
6. Global Market Demand Analysis 2018 to 2022 and Forecast, 2023 to 2033
6.1. Historical Market Analysis, 2018 to 2022
6.2. Current and Future Market Projections, 2023 to 2033
6.3. Y-o-Y Growth Trend Analysis
7. Global Market Value Analysis 2018 to 2022 and Forecast, 2023 to 2033
7.1. Historical Market Value (US$ Million) Analysis, 2018 to 2022
7.2. Current and Future Market Value (US$ Million) Projections, 2023 to 2033
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Type
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Million) Analysis By Type, 2018 to 2022
8.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Type, 2023 to 2033
8.3.1. Reusable
8.3.2. Disposable
8.4. Market Attractiveness Analysis By Type
9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Risk Type
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Million) Analysis By Risk Type, 2018 to 2022
9.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Risk Type, 2023 to 2033
9.3.1. Minimal (AAMI Level 1)
9.3.2. Low (AAMI Level 2)
9.3.3. Moderate (AAMI Level 3)
9.3.4. High (AAMI Level 4)
9.4. Market Attractiveness Analysis By Risk Type
10. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End-Use
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Million) Analysis By End-Use, 2018 to 2022
10.3. Current and Future Market Size (US$ Million) Analysis and Forecast By End-Use, 2023 to 2033
10.3.1. Hospitals
10.3.2. Clinics
10.3.3. Ambulatory Surgical Centers
10.3.4. Other End-uses
10.4. Market Attractiveness Analysis By End-Use
11. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
11.1. Introduction
11.2. Historical Market Size (US$ Million) Analysis By Region, 2018 to 2022
11.3. Current Market Size (US$ Million) & Analysis and Forecast By Region, 2023 to 2033
11.3.1. North America
11.3.2. Latin America
11.3.3. Europe
11.3.4. Asia Pacific
11.3.5. Middle East and Africa (MEA)
11.4. Market Attractiveness Analysis By Region
12. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033
12.1. Introduction
12.2. Pricing Analysis
12.3. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
12.4. Market Size (US$ Million) & Forecast By Market Taxonomy, 2023 to 2033
12.4.1. By Country
12.4.1.1. USA
12.4.1.2. Canada
12.4.1.3. Rest of North America
12.4.2. By Type
12.4.3. By End-Use
12.4.4. By Risk Type
12.5. Market Attractiveness Analysis
12.5.1. By Country
12.5.2. By Type
12.5.3. By End-Use
12.5.4. By Risk Type
13. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033
13.1. Introduction
13.2. Pricing Analysis
13.3. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
13.4. Market Size (US$ Million) & Forecast By Market Taxonomy, 2023 to 2033
13.4.1. By Country
13.4.1.1. Brazil
13.4.1.2. Mexico
13.4.1.3. Rest of Latin America
13.4.2. By Type
13.4.3. By End-Use
13.4.4. By Risk Type
13.5. Market Attractiveness Analysis
13.5.1. By Country
13.5.2. By Type
13.5.3. By End-Use
13.5.4. By Risk Type
14. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033
14.1. Introduction
14.2. Pricing Analysis
14.3. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
14.4. Market Size (US$ Million) & Forecast By Market Taxonomy, 2023 to 2033
14.4.1. By Country
14.4.1.1. Germany
14.4.1.2. France
14.4.1.3. United Kingdom
14.4.1.4. Italy
14.4.1.5. Benelux
14.4.1.6. Nordic Countries
14.4.1.7. Rest of Europe
14.4.2. By Type
14.4.3. By End-Use
14.4.4. By Risk Type
14.5. Market Attractiveness Analysis
14.5.1. By Country
14.5.2. By Type
14.5.3. By End-Use
14.5.4. By Risk Type
15. Asia Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033
15.1. Introduction
15.2. Pricing Analysis
15.3. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
15.4. Market Size (US$ Million) & Forecast By Market Taxonomy, 2023 to 2033
15.4.1. By Country
15.4.1.1. China
15.4.1.2. Japan
15.4.1.3. South Korea
15.4.1.4. Rest of Asia Pacific
15.4.2. By Type
15.4.3. By End-Use
15.4.4. By Risk Type
15.5. Market Attractiveness Analysis
15.5.1. By Country
15.5.2. By Type
15.5.3. By End-Use
15.5.4. By Risk Type
16. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033
16.1. Introduction
16.2. Pricing Analysis
16.3. Historical Market Size (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
16.4. Market Size (US$ Million) & Forecast By Market Taxonomy, 2023 to 2033
16.4.1. By Country
16.4.1.1. GCC Countries
16.4.1.2. South Africa
16.4.1.3. Turkey
16.4.1.4. Rest of Middle East and Africa
16.4.2. By Type
16.4.3. By End-Use
16.4.4. By Risk Type
16.5. Market Attractiveness Analysis
16.5.1. By Country
16.5.2. By Type
16.5.3. By End-Use
16.5.4. By Risk Type
17. Key Countries Market Analysis 2018 to 2022 and Forecast 2023 to 2033
17.1. Introduction
17.1.1. Market Value Proportion Analysis, By Key Countries
17.1.2. Global Vs. Country Growth Comparison
17.2. US Market Analysis
17.2.1. Value Proportion Analysis by Market Taxonomy
17.2.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
17.2.2.1. By Type
17.2.2.2. By End-Use
17.2.2.3. By Risk Type
17.3. Canada Market Analysis
17.3.1. Value Proportion Analysis by Market Taxonomy
17.3.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
17.3.2.1. By Type
17.3.2.2. By End-Use
17.3.2.3. By Risk Type
17.4. Mexico Market Analysis
17.4.1. Value Proportion Analysis by Market Taxonomy
17.4.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
17.4.2.1. By Type
17.4.2.2. By End-Use
17.4.2.3. By Risk Type
17.5. Brazil Market Analysis
17.5.1. Value Proportion Analysis by Market Taxonomy
17.5.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
17.5.2.1. By Type
17.5.2.2. By End-Use
17.5.2.3. By Risk Type
17.6. Germany Market Analysis
17.6.1. Value Proportion Analysis by Market Taxonomy
17.6.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
17.6.2.1. By Type
17.6.2.2. By End-Use
17.6.2.3. By Risk Type
17.7. France Market Analysis
17.7.1. Value Proportion Analysis by Market Taxonomy
17.7.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
17.7.2.1. By Type
17.7.2.2. By End-Use
17.7.2.3. By Risk Type
17.8. Italy Market Analysis
17.8.1. Value Proportion Analysis by Market Taxonomy
17.8.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
17.8.2.1. By Type
17.8.2.2. By End-Use
17.8.2.3. By Risk Type
17.9. BENELUX Market Analysis
17.9.1. Value Proportion Analysis by Market Taxonomy
17.9.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
17.9.2.1. By Type
17.9.2.2. By End-Use
17.9.2.3. By Risk Type
17.10. UK Market Analysis
17.10.1. Value Proportion Analysis by Market Taxonomy
17.10.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
17.10.2.1. By Type
17.10.2.2. By End-Use
17.10.2.3. By Risk Type
17.11. Nordic Countries Market Analysis
17.11.1. Value Proportion Analysis by Market Taxonomy
17.11.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
17.11.2.1. By Type
17.11.2.2. By End-Use
17.11.2.3. By Risk Type
17.12. China Market Analysis
17.12.1. Value Proportion Analysis by Market Taxonomy
17.12.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
17.12.2.1. By Type
17.12.2.2. By End-Use
17.12.2.3. By Risk Type
17.13. Japan Market Analysis
17.13.1. Value Proportion Analysis by Market Taxonomy
17.13.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
17.13.2.1. By Type
17.13.2.2. By End-Use
17.13.2.3. By Risk Type
17.14. South Korea Market Analysis
17.14.1. Value Proportion Analysis by Market Taxonomy
17.14.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
17.14.2.1. By Type
17.14.2.2. By End-Use
17.14.2.3. By Risk Type
17.15. GCC Countries Market Analysis
17.15.1. Value Proportion Analysis by Market Taxonomy
17.15.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
17.15.2.1. By Type
17.15.2.2. By End-Use
17.15.2.3. By Risk Type
17.16. South Africa Market Analysis
17.16.1. Value Proportion Analysis by Market Taxonomy
17.16.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
17.16.2.1. By Type
17.16.2.2. By End-Use
17.16.2.3. By Risk Type
17.17. Turkey Market Analysis
17.17.1. Value Proportion Analysis by Market Taxonomy
17.17.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
17.17.2.1. By Type
17.17.2.2. By End-Use
17.17.2.3. By Risk Type
17.17.3. Competition Landscape and Player Concentration in the Country
18. Market Structure Analysis
18.1. Market Analysis by Tier of Companies
18.2. Market Concentration
18.3. Market Share Analysis of Top Players
18.4. Market Presence Analysis
18.4.1. By Regional footprint of Players
18.4.2. Product footprint by Players
19. Competition Analysis
19.1. Competition Dashboard
19.2. Competition Benchmarking
19.3. Competition Deep Dive
19.3.1. 3M
19.3.1.1. Overview
19.3.1.2. Product Portfolio
19.3.1.3. Sales Footprint
19.3.1.4. Strategy Overview
19.3.2. Cardinal Health
19.3.2.1. Overview
19.3.2.2. Product Portfolio
19.3.2.3. Sales Footprint
19.3.2.4. Strategy Overview
19.3.3. Mölnlycke Health Care
19.3.3.1. Overview
19.3.3.2. Product Portfolio
19.3.3.3. Sales Footprint
19.3.3.4. Strategy Overview
19.3.4. Steris
19.3.4.1. Overview
19.3.4.2. Product Portfolio
19.3.4.3. Sales Footprint
19.3.4.4. Strategy Overview
19.3.5. Paul Hartmann AG
19.3.5.1. Overview
19.3.5.2. Product Portfolio
19.3.5.3. Sales Footprint
19.3.5.4. Strategy Overview
19.3.6. Standard Textile Co.
19.3.6.1. Overview
19.3.6.2. Product Portfolio
19.3.6.3. Sales Footprint
19.3.6.4. Strategy Overview
19.3.7. Medline Industries, Inc.
19.3.7.1. Overview
19.3.7.2. Product Portfolio
19.3.7.3. Sales Footprint
19.3.7.4. Strategy Overview
19.3.8. Priontex
19.3.8.1. Overview
19.3.8.2. Product Portfolio
19.3.8.3. Sales Footprint
19.3.8.4. Strategy Overview
19.3.9. OneMed
19.3.9.1. Overview
19.3.9.2. Product Portfolio
19.3.9.3. Sales Footprint
19.3.9.4. Strategy Overview
19.3.10. Medic
19.3.10.1. Overview
19.3.10.2. Product Portfolio
19.3.10.3. Sales Footprint
19.3.10.4. Strategy Overview
20. Assumptions and Acronyms Used
21. Research Methodology
Explore Healthcare Insights
View Reports